文献速递神经肿瘤小儿神经外科与脑积水

磁共振成像(MRI)常规监测筛查在儿童低级别中枢神经系统(CNS)肿瘤中检测肿瘤复发的效用:一项系统综述

The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.
PubMed 文献 · J Neurooncol · 2018-06-09

该系统综述检索截至2017年1月的12个数据库,纳入7项回顾性病例系列研究(n=370例),评估MRI监测在儿童低级别CNS肿瘤中的效用。诊断产出率为0.25%至2%,复发率为5%至41%,多数复发无症状(65%至100%);56%的复发发生在治疗后第一年内。作者认为现有证据不足,需在随机对照试验(RCT)中评估。

要点

  • 纳入7项回顾性病例系列(n=370例),平均随访5.6至7年,未发现RCT。
  • 诊断产出率0.25%至2%,复发率5%至41%,多数复发无症状(65%至100%)。
  • 56%的复发发生在治疗后第一年内,68%至第二年,90%至第五年。

核心结论

  • 本系统综述凸显目前评估MRI监测效用的证据匮乏,尽管其为常规临床实践且对患者、家庭和医疗系统造成花费。
  • 作者认为需在RCT背景下进行评估。

研究设计与样本

  • 采用标准系统综述方法,检索12个数据库至2017年1月。
  • 纳入7项回顾性病例系列研究,共370例患者,平均随访5.6至7年;未发现RCT。
  • 因研究异质性仅进行描述性综合。

主要发现

  • 影像检查在术后第一年最频繁(2至4次扫描),第二年减少至约一半频率,此后随访期间每年一次。
  • 诊断产出率范围为0.25%至2%。
  • 复发率范围为5%至41%,多数复发无症状(范围65%至100%)。
  • 合计56%的复发发生在治疗后第一年内(46%在前6个月),68%至第二年,90%至第五年。
  • 复发后90%的患者接受治疗改变,主要为再次手术(72%);五年总生存率范围为96%至100%,五年无复发生存率范围为67%至100%。

局限性

  • 未发现RCT。
  • 因研究异质性仅能进行描述性综合。
  • 无研究报告生活质量指标。
  • 作者认为需在RCT背景下评估MRI监测的效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnetic resonance imaging (MRI) is routinely used as a surveillance tool to detect early asymptomatic tumour recurrence with a view to improving patient outcomes. This systematic review aimed to assess its utility in children with low-grade CNS tumours. METHODS: Using standard systematic review methods, twelve databases were searched up to January 2017. RESULTS: Seven retrospective case series studies (n = 370 patients) were included, with average follow-up ranging from 5.6 to 7 years. No randomised controlled trials (RCTs) were identified. Due to study heterogeneity only a descriptive synthesis could be undertaken. Imaging was most frequent in the first year post-surgery (with 2-4 scans) reducing to around half this frequency in year two and annually thereafter for the duration of follow-up. Diagnostic yield ranged from 0.25 to 2%. Recurrence rates ranged from 5 to 41%, with most recurrences asymptomatic (range 65-100%). Collectively, 56% of recurrences had occurred within the first year post-treatment (46% in the first 6-months), 68% by year two and 90% by year five. Following recurrence, 90% of patients underwent treatment changes, mainly repeat surgery (72%). Five-year OS ranged from 96 to 100%, while five-year recurrence-free survival ranged from 67 to 100%. None of the studies reported quality of life measures. CONCLUSION: This systematic review highlights the paucity of evidence currently available to assess the utility of MRI surveillance despite it being routine clinical practice and costly to patients, their families and healthcare systems. This needs to be evaluated within the context of an RCT.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Stevens SP, Main C, Bailey S, et al. The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review. J Neurooncol. 2018. PMID: 29948767. doi:10.1007/s11060-018-2901-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。